Simon P. Fricker

6.1k total citations · 1 hit paper
81 papers, 4.9k citations indexed

About

Simon P. Fricker is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Simon P. Fricker has authored 81 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 25 papers in Immunology and 16 papers in Molecular Biology. Recurrent topics in Simon P. Fricker's work include Chemokine receptors and signaling (21 papers), Metal complexes synthesis and properties (16 papers) and Immunotherapy and Immune Responses (15 papers). Simon P. Fricker is often cited by papers focused on Chemokine receptors and signaling (21 papers), Metal complexes synthesis and properties (16 papers) and Immunotherapy and Immune Responses (15 papers). Simon P. Fricker collaborates with scholars based in United Kingdom, United States and France. Simon P. Fricker's co-authors include Beverly A. Teicher, Gary Bridger, R. G. Buckley, Jean Labrecque, Frances R. Balkwill, George D. Wilbanks, Julia L. Wilson, Gordon Stamp, Chris J. Scotton and Kate A Scott and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Journal of Biological Chemistry.

In The Last Decade

Simon P. Fricker

79 papers receiving 4.8k citations

Hit Papers

CXCL12 (SDF-1)/CXCR4 Pathway in Cancer 2010 2026 2015 2020 2010 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
    2010 1.2k citations Simon P. Fricker et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon P. Fricker United Kingdom 31 2.8k 1.2k 1.2k 1.1k 534 81 4.9k
Charles Eigenbrot United States 46 2.3k 0.8× 900 0.7× 4.1k 3.3× 1.6k 1.4× 714 1.3× 120 8.4k
Richard A. Miller United States 41 1.3k 0.5× 1.4k 1.1× 1.9k 1.6× 452 0.4× 709 1.3× 131 5.8k
Christopher R. Chitambar United States 36 1.3k 0.5× 343 0.3× 1.5k 1.2× 474 0.4× 359 0.7× 117 4.5k
Felix Kratz Germany 51 2.7k 1.0× 359 0.3× 5.0k 4.1× 1.8k 1.6× 1.2k 2.2× 137 10.3k
Iduna Fichtner Germany 49 2.9k 1.0× 964 0.8× 3.9k 3.2× 930 0.8× 239 0.4× 242 8.1k
Patrick T. Gunning Canada 37 2.0k 0.7× 586 0.5× 2.1k 1.7× 680 0.6× 301 0.6× 127 4.0k
Petra Heffeter Austria 47 3.9k 1.4× 298 0.2× 2.5k 2.1× 2.8k 2.5× 912 1.7× 190 7.4k
Michael Seitz Germany 38 920 0.3× 1.1k 0.9× 539 0.4× 1.2k 1.0× 1.8k 3.3× 107 4.9k
Patrycja Nowak‐Sliwinska Switzerland 39 1.8k 0.6× 402 0.3× 1.9k 1.5× 945 0.8× 649 1.2× 101 5.0k
Carleen Cullinane Australia 45 1.9k 0.7× 229 0.2× 2.5k 2.0× 942 0.8× 274 0.5× 155 5.2k

Countries citing papers authored by Simon P. Fricker

Since Specialization
Citations

This map shows the geographic impact of Simon P. Fricker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon P. Fricker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon P. Fricker more than expected).

Fields of papers citing papers by Simon P. Fricker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon P. Fricker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon P. Fricker. The network helps show where Simon P. Fricker may publish in the future.

Co-authorship network of co-authors of Simon P. Fricker

This figure shows the co-authorship network connecting the top 25 collaborators of Simon P. Fricker. A scholar is included among the top collaborators of Simon P. Fricker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon P. Fricker. Simon P. Fricker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Fricker, Simon P.. (2018). Nitrogen Monoxide-Related Disease and Nitrogen Monoxide Scavengers as Potential Drugs. PubMed. 36. 665–721. 1 indexed citations
4.
Fricker, Simon P.. (2013). Physiology and Pharmacology of Plerixafor. Transfusion Medicine and Hemotherapy. 40(4). 237–245. 57 indexed citations
5.
Fricker, Simon P.. (2011). Strategies for the Biological Evaluation of Gold Anticancer Agents. Anti-Cancer Agents in Medicinal Chemistry. 11(10). 940–952. 9 indexed citations
6.
Labrecque, Jean, Markus Metz, Gloria Lau, et al.. (2011). HIV-1 entry inhibition by small-molecule CCR5 antagonists: A combined molecular modeling and mutant study using a high-throughput assay. Virology. 413(2). 231–243. 21 indexed citations
7.
Calandra, Gary, Gary Bridger, & Simon P. Fricker. (2010). CXCR4 in Clinical Hematology. Current topics in microbiology and immunology. 341. 173–191. 37 indexed citations
8.
Fricker, Simon P.. (2008). A novel CXCR4 antagonist for hematopoietic stem cell mobilization. Expert Opinion on Investigational Drugs. 17(11). 1749–1760. 18 indexed citations
9.
Wong, Rebecca S.Y., V. Bodart, Markus Metz, et al.. (2008). Comparison of the Potential Multiple Binding Modes of Bicyclam, Monocylam, and Noncyclam Small-Molecule CXC Chemokine Receptor 4 Inhibitors. Molecular Pharmacology. 74(6). 1485–1495. 106 indexed citations
10.
Juaréz, Julius, Aileen Dela Peňa, Rana Baraz, et al.. (2007). CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment. Leukemia. 21(6). 1249–1257. 109 indexed citations
11.
Larochelle, André, Allen E. Krouse, Mark E. Metzger, et al.. (2006). AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. Blood. 107(9). 3772–3778. 142 indexed citations
12.
Chen, Jing, André Larochelle, Simon P. Fricker, et al.. (2006). Mobilization as a preparative regimen for hematopoietic stem cell transplantation. Blood. 107(9). 3764–3771. 59 indexed citations
13.
Labrecque, Jean, et al.. (2005). The Development of an Europium-GTP Assay to Quantitate Chemokine Antagonist Interactions for CXCR4 and CCR5. Assay and Drug Development Technologies. 3(6). 637–648. 14 indexed citations
14.
Fricker, Simon P., et al.. (2005). The ruthenium-based nitric oxide scavenger, AMD6221, augments cardiovascular responsiveness to noradrenaline in rats with streptozotocin-induced diabetes. European Journal of Pharmacology. 528(1-3). 132–136. 15 indexed citations
15.
Schols, Dominique, Kurt Vermeire, Sigrid Hatse, et al.. (2004). In vitro anti-HIV activity profile of AMD887, a novel CCR5 antagonist, in combination with the CXCR4 inhibitor AMD070. 5 indexed citations
16.
Marmion, Celine J., et al.. (2004). Ruthenium as an Effective Nitric Oxide Scavenger. Current Topics in Medicinal Chemistry. 4(15). 1585–1603. 23 indexed citations
17.
Mayers, Irvin, Thomas S. Hurst, Anna Radomski, et al.. (2003). Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavenger. Journal of Thoracic and Cardiovascular Surgery. 125(3). 661–668. 19 indexed citations
18.
Mosi, Renée, et al.. (2002). Mechanistic Studies on AMD6221: A Ruthenium-Based Nitric Oxide Scavenger. Biochemical and Biophysical Research Communications. 292(2). 519–529. 28 indexed citations
19.
Fricker, Simon P., et al.. (2001). The in vitro antitumour profile of some 1,2-diaminocyclohexane organotin complexes. Journal of Inorganic Biochemistry. 83(2-3). 217–221. 56 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles Eigenbrot Breakdown of academic impact, for papers by Richard A. Miller Breakdown of academic impact, for papers by Christopher R. Chitambar Breakdown of academic impact, for papers by Felix Kratz Breakdown of academic impact, for papers by Iduna Fichtner Breakdown of academic impact, for papers by Patrick T. Gunning Breakdown of academic impact, for papers by Petra Heffeter Breakdown of academic impact, for papers by Michael Seitz Breakdown of academic impact, for papers by Patrycja Nowak‐Sliwinska Breakdown of academic impact, for papers by Carleen Cullinane
Rankless by CCL
2026